StockData
Exagen Inc. logo

Exagen Inc. (XGN) stock

XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.76−0.01 (-0.27%)

Close on Nov 17, 2026Market cap $91.09MP/E –Yield –

Exagen total assets

Total assets on the balance sheet at the end of each period.

Exagen's total assets was $51.94M at Jun 30, 2026. For fiscal 2025 it was $58.02M, up 29.8% from the year before. The highest annual figure on record is $123.45M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$58.02M+29.8%
FY2024Dec 31, 2024$44.69M-21.5%
FY2023Dec 31, 2023$56.94M-34.0%
FY2022Dec 31, 2022$86.22M-30.2%
FY2021Dec 31, 2021$123.45M+57.5%
FY2020Dec 31, 2020$78.38M-11.3%
FY2019Dec 31, 2019$88.31M+205.7%
FY2018Dec 31, 2018$28.89M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$51.94M-11.6%
Q1 FY2026Mar 31, 2026$51.96M+28.9%
Q4 FY2025Dec 31, 2025$58.02M+29.8%
Q3 FY2025Sep 30, 2025$62.82M+44.1%
Q2 FY2025Jun 30, 2025$58.76M+19.2%
Q1 FY2025Mar 31, 2025$40.29M-20.7%
Q4 FY2024Dec 31, 2024$44.69M-21.5%
Q3 FY2024Sep 30, 2024$43.61M-28.4%
Q2 FY2024Jun 30, 2024$49.31M-23.2%
Q1 FY2024Mar 31, 2024$50.81M-35.9%
Q4 FY2023Dec 31, 2023$56.94M-34.0%
Q3 FY2023Sep 30, 2023$60.93M-40.0%
Q2 FY2023Jun 30, 2023$64.18M-39.9%
Q1 FY2023Mar 31, 2023$79.23M-35.1%
Q4 FY2022Dec 31, 2022$86.22M-30.2%
Q3 FY2022Sep 30, 2022$101.60M-20.5%
Q2 FY2022Jun 30, 2022$106.85M-19.9%
Q1 FY2022Mar 31, 2022$122.04M-11.3%
Q4 FY2021Dec 31, 2021$123.45M+57.5%
Q3 FY2021Sep 30, 2021$127.77M+59.7%
Q2 FY2021Jun 30, 2021$133.32M+65.6%
Q1 FY2021Mar 31, 2021$137.52M+62.5%
Q4 FY2020Dec 31, 2020$78.38M-11.3%
Q3 FY2020Sep 30, 2020$79.99M-13.7%
Q2 FY2020Jun 30, 2020$80.51M+178.7%
Q1 FY2020Mar 31, 2020$84.64M–
Q4 FY2019Dec 31, 2019$88.31M–
Q3 FY2019Sep 30, 2019$92.74M–
Q4 FY2018Dec 31, 2018$28.89M–

More Exagen figures

See a number that looks wrong?